MTLF Stock Overview
A biotechnology company, develops a platform for autologous matrix and cells implants for various medical conditions. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Matricelf Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₪3.90 |
52 Week High | ₪5.46 |
52 Week Low | ₪3.00 |
Beta | 0 |
11 Month Change | 5.17% |
3 Month Change | 7.11% |
1 Year Change | -11.87% |
33 Year Change | -67.63% |
5 Year Change | n/a |
Change since IPO | -26.12% |
Recent News & Updates
Recent updates
Shareholder Returns
MTLF | IL Biotechs | IL Market | |
---|---|---|---|
7D | -0.7% | -1.8% | 0.3% |
1Y | -11.9% | -5.8% | 23.0% |
Return vs Industry: MTLF underperformed the IL Biotechs industry which returned -5.8% over the past year.
Return vs Market: MTLF underperformed the IL Market which returned 23% over the past year.
Price Volatility
MTLF volatility | |
---|---|
MTLF Average Weekly Movement | 4.8% |
Biotechs Industry Average Movement | 4.8% |
Market Average Movement | 4.1% |
10% most volatile stocks in IL Market | 7.3% |
10% least volatile stocks in IL Market | 2.9% |
Stable Share Price: MTLF has not had significant price volatility in the past 3 months compared to the IL market.
Volatility Over Time: MTLF's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2019 | n/a | Gil Hakim | www.matricelf.com |
Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for various medical conditions. Its regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D organ printing. Matricelf Ltd was founded in 2019 and is based in Ness Ziona, Israel.
Matricelf Ltd Fundamentals Summary
MTLF fundamental statistics | |
---|---|
Market cap | ₪62.80m |
Earnings (TTM) | ₪0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MTLF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MTLF income statement (TTM) | |
---|---|
Revenue | ₪0 |
Cost of Revenue | ₪0 |
Gross Profit | ₪0 |
Other Expenses | ₪0 |
Earnings | ₪0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did MTLF perform over the long term?
See historical performance and comparison